Register Login

FASTENAL CO (FAST)

Papenfuss Donnalee Kathleen 🟡 adjusted position in 9.3K shares (2 derivative) of FASTENAL CO (FAST) at $51.42 Transaction Date: Aug 13, 2026 | Filing ID: 000005

Full text
Register to leave comments
  • News bot Aug. 17, 2026, 3:20 p.m.

    🔍 Papenfuss Donnalee Kathleen (Executive)

    Company: FASTENAL CO (FAST)

    Report Date: 2026-08-13

    Transaction Summary:

    • Total transactions: 7
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 9,258
    • Total shares sold: 18,516
    • Total shares held: 811

    Detailed Transactions and Holdings:

    • Acquired 1,364 shares of Common Stock at $13.75 per share (Direct)
      Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 1,364.00 | transaction_form_type: 4
    • Sold 1,364 shares of Common Stock at $51.4165 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Acquired 7,894 shares of Common Stock at $19.0 per share (Direct)
      Date: 2026-08-13 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,894.00 | transaction_form_type: 4
    • Sold 7,894 shares of Common Stock at $51.3841 per share (Direct)
      Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-13 | Code: H | nature_of_ownership: Held in 401(K) Plan | shares_owned_after: 811.00 | Footnotes: F1
    • Sold 1,364 shares of Employee Stock Option (Right to Buy) at $13.75 per share (Derivative)
      Date: 2026-08-13 | Code: M | Expires: 2027-12-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2
    • Sold 7,894 shares of Employee Stock Option (Right to Buy) at $19.0 per share (Derivative)
      Date: 2026-08-13 | Code: M | Expires: 2029-12-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F3, F4, F3

    Footnotes:

    • F1: Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 345 shares acquired in the account since the last report on 6/9/2025.
    • F2: The option will vest and become exercisable over a period of eight years, with 25% of the option vesting and becoming exercisable two years after the relevant vesting period, and the remainder vesting and becoming exercisable proportionately each year thereafter.
    • F3: The option was previously reported in a Form 3 filing on 11/6/2024 and the amounts reported on this Form 4 are adjusted to reflect a 2-for-1 stock split on May 21, 2025.
    • F4: The option will vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable two years following the date of grant, and the remainder vesting and becoming exercisable proportionately on each anniversary of the grant date.

Search

News categories